All filters
Abstracts
Time to treatment disfavors patients living with HIV/HCV co-infection
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Prevalence of alcohol and substance use in a sample of patients living with HIV/HCV co-infection who are in routine clinical care receiving antiretroviral therapy
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Efficacy and safety of sofosbuvir/velpatasvir for the treatment of patients with chronic hepatitis C genotype 1-6 infection: Integrated analysis of eight Phase 3 clinical trials
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Heterogeneity in priorities for continuing education training among clinicians providing (or not!) HIV and HCV clinical services
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Automated electrochemiluminescence assay could be used for screening hepatitis B and C markers in dried blood spot samples?
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
96 Week efficacy and safety of B/F/TAF in treatment-naïve adults and adults ≥ 50 years
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Tenofovir alafenamide vs tenofovir DF in women: Pooled analysis of 7 clinical trials
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Associations between hepatitis C and social determinants of health in a sample of injecting drug users living with HIV in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Sociodemographic, health-related factors and behavioral practices among people who inject drugs: Data from the PR NHBS-PWID 3 (2012) and NHBS-PWID 4 (2015)
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Provider-Initiated HIV testing predictors among heterosexuals at increased risk of HIV in Puerto Rico: Data from NHBS – HET cycle, 2016
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Hurricane Maria’s viral impact: HIV care outcomes among substance users in Puerto Rico following hurricane Maria
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
E-Posters
Prevalence of Hepatitis B Virus and Vaccine Antibody Titers Among HIV Positive and Negative Infants in Botswana - Lynnette N. Bhebhe
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Variceal Recurrence 4 years beyond Endoscopic Band Ligationin Hepatitis C Patients who Achieved Sustained Virological Response Post Direct Acting Antiviral Therapies - Mohamed Abdel-Samiee
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Prevalence of hepatocellular carcinoma in Chronic Hepatitis B Genotype E African patients – a single centre experience - Zillah Cargill
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Feasibility of the Public Health Approach in the Management of Hepatitis C Virus (HCV) in Nigeria, using the Pangenotypic Direct Acting Antiviral (DAAs) - Chukwuemeka Agwuocha
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Possible Role of Natural Killer Cells in Hepatitis C Virus Related Hepatocellular Carcinoma - Eman Abdelsameea
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Awareness Of Preventive Measures Against Hepatitis B Infection Among Pregnant Women Attending A Tertiary Health Facility In Osun State, Nigeria - T. Oladosu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Évaluation De L'État Des Connaissances Sur L'Hépatite Virale B Des Patients En Consultation D'Hépato-Gastroentérologie À L'Hôpital General Idrissa Pouye (Dakar, Senegal) - M. N. Gueye
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Profil Epidemiologique Diagnostique Et Therapeutique Des Patients Porteurs Du Virus De L’Hepatite C: À Propos De 26 Cas - Fall Marième Polèle
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Epidemiological Profile Of Hepatitis B Cases In Baringo County, Kenya, 2018 - R. Rono
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Marqueurs Biologiques De L'Hépatite Virale B A L’Initiation Du Traitement Antiviral En Ambulatoire Au Service Des Maladies Infectieuses Du Chu Du Point G, Bamako, Mali - H. Hamidou Issa
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Seroprevalence And Associated Risk Factors For Hepatitis B Virus Infection Among Barbers And Their Clients In Two Cities Of Cameroon - Ngoupa Joël Brice
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Risk Of Liver Disease Among Blood Donors Infected With Hepatitis C Virus - E. Jimah
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
E-Posters
Can Treatment For Hepatitis C Virus In Resource-Constrained Settings Improve Case Finding And Control Of Highly Prevalent Chronic Co-Morbidities? Secondary Analysis From The Shared Study In Rwanda - F. Shumbusho
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020